Harlan S Robins Adaptive Biotechnologies Corp (ADPT) insider trading activity

Harlan S Robins is Chief Scientific Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 1.02 Million shares of ADPT, which is worth approximately $5.17 Million. The most recent transaction as insider was on Apr 22, 2021, when has been sold 7,790 shares (Common Stock) at a price of $43.22 per share, resulting in proceeds of $336,684. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.02M

0% 3M change

53.2% 12M change

Total Value Held $5.17 Million

HARLAN S ROBINS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 22 2021	SELL Open market or private sale	$336,684 $43.22 p/Share	7,790 Reduced 10.1%	69,360 Common Stock
Apr 22 2021	BUY Exercise of conversion of derivative security	$49,233 $6.32 p/Share	7,790 Added 9.17%	77,150 Common Stock
Apr 21 2021	SELL Open market or private sale	$318,923 $40.94 p/Share	7,790 Reduced 10.1%	69,360 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$49,233 $6.32 p/Share	7,790 Added 9.17%	77,150 Common Stock
Apr 20 2021	SELL Open market or private sale	$476,748 $40.8 p/Share	11,685 Reduced 14.42%	69,360 Common Stock
Apr 20 2021	BUY Exercise of conversion of derivative security	$73,849 $6.32 p/Share	11,685 Added 12.6%	81,045 Common Stock
Mar 25 2021	SELL Open market or private sale	$203,295 $38.43 p/Share	5,290 Reduced 7.09%	69,360 Common Stock
Mar 25 2021	BUY Exercise of conversion of derivative security	$33,433 $6.32 p/Share	5,290 Added 6.62%	74,650 Common Stock
Mar 24 2021	SELL Open market or private sale	$259,061 $40.51 p/Share	6,395 Reduced 8.44%	69,360 Common Stock
Mar 24 2021	BUY Exercise of conversion of derivative security	$40,416 $6.32 p/Share	6,395 Added 7.78%	75,755 Common Stock
Mar 23 2021	SELL Open market or private sale	$326,635 $41.93 p/Share	7,790 Reduced 10.1%	69,360 Common Stock
Mar 23 2021	BUY Exercise of conversion of derivative security	$49,233 $6.32 p/Share	7,790 Added 9.17%	77,150 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	68,681 Added 49.75%	69,360 Common Stock
Feb 03 2021	SELL Open market or private sale	$466,777 $59.92 p/Share	7,790 Reduced 91.98%	679 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$49,233 $6.32 p/Share	7,790 Added 47.91%	8,469 Common Stock
Feb 02 2021	SELL Open market or private sale	$465,141 $59.71 p/Share	7,790 Reduced 91.98%	679 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$49,233 $6.32 p/Share	7,790 Added 47.91%	8,469 Common Stock
Feb 01 2021	SELL Open market or private sale	$435,149 $55.86 p/Share	7,790 Reduced 91.98%	679 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$49,233 $6.32 p/Share	7,790 Added 47.91%	8,469 Common Stock
Jan 21 2021	SELL Open market or private sale	$1,562,284 $66.85 p/Share	23,370 Reduced 97.18%	679 Common Stock
Jan 21 2021	BUY Exercise of conversion of derivative security	$147,698 $6.32 p/Share	23,370 Added 49.28%	24,049 Common Stock
Jan 20 2021	SELL Open market or private sale	$3,374,000 $67.48 p/Share	50,000 Reduced 98.66%	679 Common Stock
Jan 20 2021	BUY Exercise of conversion of derivative security	$316,000 $6.32 p/Share	50,000 Added 49.66%	50,679 Common Stock
Jan 19 2021	SELL Open market or private sale	$3,447,500 $68.95 p/Share	50,000 Reduced 98.66%	679 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$316,000 $6.32 p/Share	50,000 Added 49.66%	50,679 Common Stock

HSR

Harlan S Robins

Chief Scientific Officer

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account